Pharmacists in Dexter, ME Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Dr. Peter S Mclean, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 188 Spring St, Dexter, ME 04930 Phone: 207-924-7000 |
 Cynthia Thibodeau Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 37 Church St, Dexter, ME 04930 Phone: 207-924-6259 Fax: 207-924-9710 |
William Agnew, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 188 Spring St, Dexter, ME 04930 Phone: 207-924-7000 |
Julie Dow Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 37 Church St, Dexter, ME 04930 Phone: 207-924-6259 Fax: 207-924-9710 |
News Archive
Food scientists develop rapid screening technique to detect pesticide residue in vegetables
Food scientists from the National University of Singapore developed a rapid and highly sensitive screening technique capable of detecting minute amounts of pyrethroids in vegetables, a common type of synthetic pesticide applied on agricultural crops. The innovative strategy makes use of magnetic nanoparticles to simplify pyrethorid extraction, reducing the screening process to under two hours.
Mortality rates higher in hepatitis C virus carriers
Hepatitis C virus (HCV) is a blood-borne disease that causes inflammation of the liver and to which there is currently no vaccine available. The World Health Organization (WHO) estimates that 3% of the world's population, approximately 170 million people, are infected with HCV and it is a leading cause of liver cirrhosis, end stage liver disease, hepatocellular carcinoma (HCC) and liver transplantation.
Merck, Glenmark settle ZETIA patent litigation
Merck & Co., Inc. and Glenmark Pharmaceuticals Inc., USA and Glenmark Pharmaceuticals, Ltd. have reached an agreement to settle their patent litigation involving Glenmark's challenge to Merck's patent covering ZETIA ® (ezetimibe). Specifically, Glenmark challenged Merck's basic compound patent, RE 37,721 (the "721 patent") on numerous grounds.
Research findings could lead to new targets for cancer-fighting therapeutics
A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study.
› Verified 9 days ago
Pharmacists
Occupational Therapists
Clinical Social Workers
Dentists
Counselors